Loomis Sayles & CO L P Sage Therapeutics, Inc. Transaction History

Loomis Sayles & CO L P

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$27.52 - $37.99 $1,816 - $2,507	-66 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$30.71 - $45.71 $2,026 - $3,016	66 New	66 $2,000
Q4 2021 Feb 14, 2022	SELL	$37.06 - $47.11 $6,151 - $7,820	-166 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$40.26 - $57.37 $6,683 - $9,523	166 New	166 $7,000
Q1 2021 May 17, 2021	SELL	$70.65 - $96.76 $13,352 - $18,287	-189 Closed	0 $0

Q4 2020 Feb 12, 2021	BUY	$58.41 - $89.06 $11,039 - $16,832	189 New	189 $16,000

223

52.7M

207K

191K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $645M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.